article thumbnail

Covid’s scientific silver lining: A chance to watch the human immune system respond in real time

STAT

While an increasingly anxious world watched a new coronavirus spread across the globe in early 2020, veteran immunologist Rafi Ahmed quickly grasped that his field was about to experience something truly extraordinary.

article thumbnail

10 fact you must know – FLU SEASON 2020/2021

Druggist

With just one month to go, flu season 2020/2021 is just around the corner. This post is a summary of essential information about flu season 2020 and flu vaccination 2020/2021. When will flu season 2020 start? This year the official start date for flu vaccination service is 01/09/2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The top 5 pharma M&A deals of 2020

pharmaphorum

2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% of total M&A deal values. Here we take a look at the biggest mergers and acquisitions of 2020 and what they might mean for the companies involved.

article thumbnail

12 facts you must know – FLU SEASON 2020/2021

Druggist

With just one month to go, flu season 2020/2021 is just around the corner. This post is a summary of essential information about flu season 2020 and flu vaccination 2020/2021. When will flu season 2020 start? This year the official start date for flu vaccination service is 01/09/2020.

article thumbnail

2023 Nobel Prize in Medicine: Karikó, Weissman awarded prize for mRNA research

STAT

Overcoming a lack of broader interest in their work and scientific challenges, Katalin Karikó and Drew Weissman made key discoveries about messenger RNA that enabled scientific teams to start developing the tool into therapies, immunizations, and — as the pandemic spread in 2020 — vaccines targeting the SARS-CoV-2 coronavirus.

article thumbnail

First nasal monoclonal antibody COVID-19 treatment shows potential

European Pharmaceutical Review

Findings from research on the nasal monoclonal antibody “Based on our studies, we expect that Foralumab may work on all variants as it acts on immune effects,” Dr Weiner continued. Foralumab’s immune modulating response In 2020, Moreira researched how Foralumab modulates the immune response to reduce inflammation.

article thumbnail

Covid vaccines averted 3 million deaths in U.S., according to new study

STAT

had relied upon so-called “natural immunity” acquired through infection as the only immunological defense against the virus. times more hospitalizations in the time since December of 2020. But the study results show the toll would have been even worse had the U.S. times more infections, and 3.8

Vaccines 142